The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two-year follow-up of KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in adult patients (Pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3.
 
Bijal D. Shah
Honoraria - BeiGene; Gilead Sciences; Pharmacyclics/Janssen; Spectrum/Acrotech
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; Kite, a Gilead company; Novartis; Pfizer; Pfizer; Precision Biosciences
Research Funding - Incyte; Jazz Pharmaceuticals (Inst); Kite/Gilead
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Janssen; Kite, a Gilead company; Novartis; Pfizer; Seagen; Stemline Therapeutics
 
Armin Ghobadi
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene; Kite, a Gilead Company; WUGEN, Inc.
Research Funding - Amgen; Kite, a Gilead Company
 
Olalekan O. Oluwole
Consulting or Advisory Role - ADC Therapeutics; Bayer; Curio Science; Kite/Gilead; Legend Biotech; Novartis; Pfizer; Spectrum Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst)
 
Aaron Logan
Consulting or Advisory Role - AbbVie; Amgen; Bristol-Myers Squibb; Pfizer
Research Funding - Amphivena Therapeutics; Astellas Pharma; Autolus; Jazz Pharmaceuticals; Kadmon; Kite, a Gilead Company; Pharmacyclics
 
Nicolas Boissel
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Kite/Gilead
Research Funding - Amgen (Inst); Merck (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Other Relationship - Autolus; Pepromene
 
Edouard Forcade
Consulting or Advisory Role - Novartis
Speakers' Bureau - Gilead Sciences; Jazz Pharmaceuticals; Novartis
Travel, Accommodations, Expenses - Gilead Sciences; Jazz Pharmaceuticals; MSD; Novartis
 
Michael Russell Bishop
Honoraria - Bristol-Myers Squibb/Celgene/Juno; Incyte; Incyte; Sanofi/Aventis
Consulting or Advisory Role - Arcellx; Autolus; BMS; crispr therapeutics; Iovance Biotherapeutics; Kite, a Gilead company; Novartis; Sana Biotechnology
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Expert Testimony - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Max S. Topp
Consulting or Advisory Role - Kite/Gilead; Kite/Gilead; Novartis; Regeneron; Roche
Research Funding - Kite, a Gilead company (Inst); Regeneron (Inst); Roche (Inst)
 
Dimitrios Tzachanis
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Partner Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb
 
Kristen M. O'Dwyer
Consulting or Advisory Role - Beam Therapeutics
 
Martha Lucia Arellano
Consulting or Advisory Role - Kite, a Gilead company; Syndax
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Maria R. Baer
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); FORMA Therapeutics (Inst); Kite, a Gilead company (Inst); Kura Oncology (Inst); Takeda (Inst)
 
Gary J. Schiller
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis; Ono Pharmaceutical
Speakers' Bureau - Amgen; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, a Gilead company; Sanofi; Stemline Therapeutics
Research Funding - Abbvie; Actinium Pharmaceuticals; Actuate Therapeutics; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb/Celgene; Celator; Constellation Pharmaceuticals; Daiichi Sankyo; Deciphera; Delta-Fly Pharma; ElevateBio; FORMA Therapeutics; Fujifilm; Gamida Cell; Genentech/Roche; Geron; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Mateon Therapeutics; Novartis; Onconova Therapeutics; Ono Pharmaceutical; Pfizer; PrECOG; REGiMMUNE; Samus Therapeutics; Sangamo Bioscience; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Takeda; Tolero Pharmaceuticals; Trovagene
 
Lang Zhou
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Petra C. Schuberth
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences; Kite, a Gilead Company
 
Sabina Adhikary
Employment - Kite, a Gilead Company
 
Behzad Kharabi Masouleh
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - GlaxoSmithKline; Kite, a Gilead Company; lava therapeutics
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Roch Houot
Honoraria - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead Company; MSD; Novartis; Roche
Consulting or Advisory Role - Gilead Sciences; Kite, a Gilead Company